⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate - Hagens Berman
accessnewswire.com
MLTX
Securities Fraud Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - Levi & Korsinsky Reminds Investors of December 15, 2025
accessnewswire.com
MLTX
MLTX LAWSUIT ALERT: The Gross Law Firm Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline
prnewswire.com
MLTX
Latest SueWallSt Podcast: What MLTX Investors Need to Know About the Lawsuit
accessnewswire.com
MLTX
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) Investors - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of MoonLake Immunotherapeutics to Contact the Firm Today!
accessnewswire.com
MLTX
Levi & Korsinsky Urges MoonLake Immunotherapeutics (MLTX) Shareholders to Act Before Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
MLTX LEGAL REMINDER: MoonLake Immunotherapeutics Faces Securities Allegations over Drug Trial Results -- Investors Alerted to Contact BFA Law before December 15
accessnewswire.com
MLTX
TSLA
Class Action Lawsuit Filed: MoonLake Immunotherapeutics (MLTX) - Join by December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Informs Shareholders of Securities Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX